# Sources — Judy Garland

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Powers N. “Garland, Judy (1922–1969),” *Women in World History: A Biographical Encyclopedia* (Gale), Encyclopedia.com. Supports her birth as Frances Ethel Gumm on June 10, 1922, in Grand Rapids, Minnesota; a studio-supervised regimen of Benzedrine to control her appetite and Seconal to counter it; “addictions to various medications for the rest of her life”; suicide attempts in the 1940s, in 1950 and in the early 1950s; hospital and sanitarium stays, including Peter Bent Brigham Hospital in Boston in 1949; the end of her studio contract in 1950; *A Star Is Born* and the Academy Award nomination; the birth of her son in March 1955; a bout of acute hepatitis in the late 1950s; and the coroner's report of an overdose of sleeping pills as the cause of her death in London on June 22, 1969. https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/garland-judy-1922-1969
2. *TIME*. “Milestones, Jun. 27, 1969.” Contemporary death notice: died in London at 47; born Frances Gumm in Grand Rapids, Minnesota, to parents in vaudeville; a national legend at 17 in *The Wizard of Oz*; attempted suicide in 1950, then concert comebacks; Oscar nominations for *A Star Is Born* and *Judgment at Nuremberg*. https://time.com/archive/6637032/milestones-jun-27-1969
3. PBS *American Masters*. “5 Interesting Facts About Judy Garland.” Supports her birth name and place, her dates (June 10, 1922 to June 22, 1969), signing with the studio at 13, the studio's control of what she ate and when she slept, and that “the pills began after” *The Wizard of Oz*. https://www.pbs.org/wnet/americanmasters/blog/5-interesting-facts-about-judy-garland
4. Haynes S. “The True Story Behind *Judy*,” *TIME*, September 26, 2019. Drawing on Gerald Clarke's biography: studio “pep pills” (amphetamines) and “downers” (barbiturates); signing at 13; publicized suicide attempts; hospitalization with acute hepatitis in 1959; the death “ruled as an accidental overdose of sleeping pills”; *A Star Is Born* and the nomination. https://time.com/5684673/judy-garland-movie-true-story/
5. Bertram C. “Judy Garland Filmed *The Wizard of Oz* Under Grueling Conditions,” Biography.com (updated December 2, 2024). Supports the studio's “pep pills” for appetite and energy, her own account (to biographer Paul Donnelley) of pills to stay on her feet and sleeping pills at the studio hospital, and Gerald Clarke's account that her mother was the first to give her pills, before she was 10. https://www.biography.com/actors/judy-garland-pills-diet-wizard-of-oz
6. Blakemore E. “Golden Age Hollywood Had a Dirty Little Secret: Drugs,” History.com, March 1, 2018. Supports that her mother introduced her to pep pills, that studio doctors prescribed pills “to control both her weight and her energy levels,” and that the regimen led to addiction. https://www.history.com/articles/judy-garland-barbiturates-hollywood-studio-drugs
7. Bertram C. “Inside Judy Garland's Final Years and Her London Concerts,” Biography.com (updated January 14, 2021). Citing her *Los Angeles Times* obituary and London press reports: “years of addiction to upper and downer prescription pills,” and that her death was “ruled as accidental, an overdose of barbiturates,” with no evidence of suicide. https://www.biography.com/actors/judy-garland-london-concerts-final-years
8. Kirkus Reviews. Review of Clarke G, *Get Happy: The Life of Judy Garland* (Random House, 2000). Supports that by her twenties she “was already dependent on pills, had attempted suicide, was treated for mental exhaustion.” https://www.kirkusreviews.com/book-reviews/gerald-clarke/get-happy/
9. Publishers Weekly. Review of Clarke G, *Get Happy*. Summarizes Clarke's account that her mother gave her amphetamines in early childhood; used only for the contested claim CLM-0004. https://www.publishersweekly.com/9780375503788
10. *TV Guide*, Philadelphia edition, September 24, 1955, through the Media History Digital Library (Lantern). Contemporary listing: the Ford Star Jubilee “begins tonight with Judy Garland's TV bow.” https://lantern.mediahist.org/catalog/tvguide-philadelphia-1955-09-24_0007
11. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Brunner E, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. American Society of Addiction Medicine with nine partner organizations, *J Gen Intern Med* 2025;40(12):2814-2859 (PMID 40526204). Used for: no abrupt discontinuation in physical dependence, shared decisions, initial reductions of 5 to 10% every 2 to 4 weeks and generally no more than 25% every 2 weeks, pausing or slowing for symptoms, switching to a longer-acting agent, inpatient care for severe or complicated withdrawal, and phenobarbital only in inpatient settings with experienced clinicians. The guideline states that barbiturates are beyond its scope; its principles are applied here by analogy. https://pubmed.ncbi.nlm.nih.gov/40526204/
2. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. *J Addict Med* 2020 (PMID 32511109): withdrawal scoring, seizure risk and the setting of withdrawal management, and phenobarbital use by experienced clinicians. https://pubmed.ncbi.nlm.nih.gov/32511109/
3. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. *J Addict Med* 2024 (PMID 38669101). https://pubmed.ncbi.nlm.nih.gov/38669101/
4. Sateia MJ, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. American Academy of Sleep Medicine, *J Clin Sleep Med* 2017 (PMID 27998379). https://pubmed.ncbi.nlm.nih.gov/27998379/
5. Qaseem A, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. *Ann Intern Med* 2016 (PMID 27136449): CBT for insomnia as first-line treatment. https://pubmed.ncbi.nlm.nih.gov/27136449/
6. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. *MMWR Recomm Rep* 2024 (PMID 39106314): enzyme-inducing anticonvulsants, including barbiturates, and the hormonal methods they weaken. https://pubmed.ncbi.nlm.nih.gov/39106314/
7. Centers for Disease Control and Prevention. Prescription Drug Monitoring Programs (PDMPs). https://www.cdc.gov/overdose-prevention/hcp/clinical-guidance/prescription-drug-monitoring-programs.html
8. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), depression, bipolar, and mood disorders monograph: PHQ-9 at least monthly in acute treatment, suicide-risk reassessment at every visit, the Mood Disorder Questionnaire at the initial depression work-up, and SSRI review two weeks after a start or dose change. https://patrickrutledge.github.io/topthirty/
9. U.S. Preventive Services Task Force: depression and suicide risk (2023), cervical cancer (2018), HIV (2019), hepatitis C (2020), tobacco (2021), intimate partner violence (2018), and the A and B recommendations. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
10. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024). https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp
11. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (PMID 36893044), and the Adult Immunization Schedule by Age. https://pubmed.ncbi.nlm.nih.gov/36893044/; https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html
12. Stachler RJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). American Academy of Otolaryngology-Head and Neck Surgery Foundation, 2018 (PMID 29494321). https://pubmed.ncbi.nlm.nih.gov/29494321/
13. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Popular writing.** Much writing about her drug use is sensational. The case uses a reference encyclopedia, a contemporary *TIME* notice, PBS, a 2019 *TIME* article, a History.com article, two Biography.com articles that name their sources, two reviews of Gerald Clarke's biography, and a 1955 *TV Guide*. The biography itself was not read; it is cited only as its reviewers and Biography.com report it. Content-farm pages found in searches were not used. *The Wizard of Oz* co-star named in some sources is not named here.
- **Who began the pills (CLM-0004, R, disputed).** Biography.com and Publishers Weekly report Clarke's account that her mother first gave her pills in early childhood; History.com says both that her mother introduced pep pills and that studio doctors prescribed them; other sources attribute them to the studio. The case relies only on what all sources agree on: the pills were given to her as a minor by adults responsible for her (CLM-0003, D). The age-four detail in one review is not used.
- **Drug names.** One source names Benzedrine and Seconal; others say “pep pills,” amphetamines, barbiturates and sleeping pills. The modern episode uses secobarbital and dextroamphetamine as present-day equivalents; they are synthetic.
- **Bipolar disorder.** The roster lists bipolar disorder. No source read documents such a diagnosis, mania or hypomania, so it is not a claim and not a modern diagnosis. The modern depression is synthetic, and the Mood Disorder Questionnaire is negative, which is also the teaching step before an antidepressant.
- **Suicide attempts and hospital stays.** Recorded once each (CLM-0006, CLM-0007), as sensitive, without method or detail; *TIME* (1969) documents the 1950 attempt, and the encyclopedia and Kirkus describe others. They appear in the modern record only as historical risk factors in the safety assessment.
- **Death.** Recorded once (CLM-0013) in one plain sentence. Sources differ slightly in wording (an overdose of barbiturates, of sleeping pills); all agree it was ruled accidental. The house, the person who found her, and the inquest details are not recorded.
- **Living relatives.** Her children are not named and nothing is attributed to them; the birth in March 1955 appears only as a dated fact, and the modern household history names no one. Her spouses are not named.
- **Index age and dates.** The index visit on June 22, 2026 maps to June 22, 1955, when she was 33: a year after *A Star Is Born*, three months after the birth of her third child, and three months before her television debut (September 24, 1955). The synthetic date of birth is June 10, 1993 (shift 71 years). The chronic-care visits on June 29, July 20, August 31 and October 26, 2026, the four-day admission on July 6 to 9, the sick visit on August 17, and the preventive visit on September 28, 2026 all map to the same days of 1955. Her location in those months is not documented in the sources read, so the episode places her only in rehearsals and performances, which agrees with the documented television work. Past medical history includes only events up to March 1955.
- **Synthetic clinical picture.** Everything in the modern episode is synthetic: the doses (secobarbital 200 to 300 mg, dextroamphetamine 10 mg with extra tablets), the three prescribers, the DSM-5-TR criteria counts, the depression and anxiety, every score (DAST-10, AUDIT-C, PHQ-9, GAD-7, and the Insomnia Severity Index and Mood Disorder Questionnaire, which have no LOINC total code and are recorded as narrative), all laboratory values, the ECG, the urine drug tests and pregnancy test (narrative only), the admission, the medicines, and the outcomes. Height (151 cm) and weights are synthetic.
- **Clinical judgment calls.** (1) Tolerance and withdrawal are not counted toward the use disorders because the drugs were prescribed under supervision (DSM-5-TR); the diagnoses rest on other criteria. (2) The barbiturate change was made in hospital because a long, high-dose short-acting barbiturate carries a risk of seizures; the conversion of about 30 mg of phenobarbital for each 100 mg of secobarbital is a commonly used clinical estimate, not taken from a cited guideline. (3) Outpatient reductions of 8.1 to 16.2 mg (12.5 to 20%) about every two weeks are faster than the benzodiazepine guideline's suggested initial 5 to 10% but within its 25% limit, chosen because phenobarbital's long half-life smooths each step; the taper was paused twice. (4) The stimulant was kept at a fixed dose and tapered only after phenobarbital was stable. (5) Naloxone was not prescribed and the reason is documented. (6) Contraception is an injection because barbiturates weaken pills, patches, rings and implants.
- **Preventive visit.** A periodic adult preventive visit at 33 (CPT 99395 with 99497 in plain text). Judgment calls: one-time HIV, hepatitis C and hepatitis B screening (results nonreactive, reported in the four-month note); cervical screening up to date from prenatal care; tobacco treatment offered and declined until after the taper; influenza vaccine given; advance care planning records an unnamed agent and her wish that treatment for the pills continue without blame.
- **Sick visit.** Acute viral laryngitis during rehearsals, chosen because it fits a singer and tests the plan: codeine and dextromethorphan were avoided with phenobarbital, no steroid or antibiotic was given, and the planned taper step was paused. It is not a historical claim.
- **Focused visits.** The four chronic-care follow-ups (one week with the consultation, four weeks, ten weeks and four months) are documented as focused visits on the 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering (by analogy), the ASAM alcohol withdrawal guideline, the ASAM/AAAP stimulant guideline, the ACP and AASM insomnia guidelines, the CMID depression monograph, the VA/DoD suicide-risk guideline, CDC prescription drug monitoring guidance and the US MEC. Two deviations are recorded instead of invented results: (1) the dietitian visit planned at intake had not happened by four weeks because of a waiting list; no harm resulted (weight rising), the clinic booked a second dietitian, and she was seen before the ten-week visit; (2) the PHQ-9 was not repeated for six weeks between the four-week and ten-week visits, longer than the monthly check advised; no harm resulted (her weekly therapist saw no worsening and the score fell), and the PHQ-9 was then done at the preventive visit and monthly. Synthetic findings introduced: a mild tremor on one night of the admission, three nights of rebound wakefulness after the last step, and a mildly raised GGT from enzyme induction.
- **Consultation.** The addiction medicine referral and the consultation by Tobias Grünewald, MD (a fictional consultant), on the day of the one-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: a moderate barbiturate and a mild stimulant use disorder; a four-day admission to change to phenobarbital; an outpatient taper of no more than about 20% every two weeks with pauses; the stimulant tapered only after phenobarbital was stable; sertraline to 50 mg with CBT for insomnia and no new hypnotic; injectable contraception; no naloxone, with the reason; urine testing after the change and at four months; and a blood count and liver tests at four months.
